Table 2.

Baseline characteristics of patients

CharacteristicGroup A (n = 19)Group B (n = 23)P
Age (years; mean ± SD)57 ± 1160 ± 9NS
Men/women8/118/15NS
Postdialysis body weight (kg; mean ± SD)57.7 ± 8.555.7 ± 13.8NS
BMI (mean ± SD)23.3 ± 3.423.2 ± 3.9NS
Diabetes (n [%])2 (10.5)5 (21.7)NS
IHD/CVA/PVD (n [%])7 (36.8)3 (13.0)NS
Causes of ESRD (n [%])
    glomerulonephritis6 (31.6)7 (30.4)
    unknown8 (42.1)7 (30.4)
    lupus nephritis1 (5.3)3 (13.0)
    hypertensive nephropathy1 (5.3)2 (8.7)
    diabetic nephropathy0 (0.0)2 (8.7)
    other3 (15.8)2 (8.7)
HD, sessions/week (thrice/twice per week)12/716/7NS
History of transplantation (n [%])4 (21.1)2 (8.7)NS
Years on PD (before HD; mean ± SD)3.4 ± 3.13.1 ± 2.9NS
Years on HD (mean ± SD)4.2 ± 3.75.1 ± 3.1NS
Total years on dialysis (PD + HD; mean ± SD)7.6 ± 3.68.2 ± 2.8NS
ACEI/ARA (n [%])7 (36.8)7 (30.4)NS
HMG-CoA reductase inhibitor (n [%])4 (21.1)2 (8.7)NS
EPO (n [%])11 (57.9)18 (78.3)NS
  • BMI, body mass index; CVA, cerebrovascular accident; EPO, erythropoietin; IHD, ischemic heart disease; PD, peritoneal dialysis; PVD, peripheral vascular disease.